(Q34385320)

1 August 2017

1 reference

title

BDNF in schizophrenia, depression and corresponding animal models (English)

1 reference

1 August 2017

0 references

Angelucci F

1

1 reference

1 August 2017

Brenè S

series ordinal

2

1 reference

1 August 2017

Mathé AA

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

1 August 2017

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

345-352

1 reference

Neurotrophin secretion: current facts and future prospects

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Schizophrenia and neurotrophin-3 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Requirement for BDNF in activity-dependent survival of cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neurotrophin trafficking by anterograde transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Coexpression of neurotrophins and their receptors in neurons of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Schizophrenia Following Pre-natal Exposure to Influenza Epidemics Between 1939 and 1960

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Prenatal development of monozygotic twins and concordance for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Perinatal complications and reduced size of brain limbic structures in familial schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Cell loss in the hippocampus of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Effects of stress on neurotrophic factor expression in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neonatal insult to the hippocampal region and schizophrenia: a review and a putative animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Partial hippocampal pyramidal cell loss alters behavior in rats: implications for an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Amygdala or ventral hippocampal lesions at two early stages of life differentially affect open field behaviour later in life; an animal model of neurodevelopmental psychopathological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neonatal damage of the ventral hippocampus impairs working memory in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Directions in neurogenetic gradients and patterns of anatomical connections in the telencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Hippocampal volume reduction in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Why stress is bad for your brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Selective breeding for sensitivity to the anticholinesterase DFP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

A cholinergic-adrenergic hypothesis of mania and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The influence of gender and the estrous cycle on learned helplessness in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Lithium in depression: a review of the antidepressant and prophylactic effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Atypical antipsychotics in bipolar and schizoaffective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Cytokine and growth factor involvement in schizophrenia--support for the developmental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Cytoarchitecture of the entorhinal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Depresssion--emerging insights from neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Research and treatment approaches to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

A Molecular and Cellular Theory of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Spatiotemporal selective effects on brain-derived neurotrophic factor andtrkB messenger RNA in rat hippocampus by electroconvulsive shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Glucocorticoids, hippocampal damage and the glutamatergic synapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

What role do atypical antipsychotic drugs have in treatment-resistant depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001637

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001637

1 reference

1 August 2017

1 reference